← Back to Search

Treadmill Training for Parkinson's Disease

N/A
Recruiting
Led By Feng Yang, PhD
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Can you walk at least 15 meters without a walking aid?
Can you walk on a treadmill for at least 15 minutes without the need of a walking aid or needing to rest?
Must not have
Have you been diagnosed with uncontrolled cardiorespiratory or metabolic diseases?
Have you been diagnosed with any other neurologic disorder (other than PD) that affects your ability to walk?
Timeline
Screening 1 days
Treatment Varies
Follow Up baseline and post-intervention (about 1 hour following the baseline)
Awards & highlights

Study Summary

This trial will explore if controlling both speed and cadence during treadmill training may elicit more benefits than controlling speed alone in individuals with Parkinson's disease.

Who is the study for?
This trial is for individuals aged 18-89 with Parkinson's Disease who can walk at least 15 meters unaided and use a treadmill for at least 15 minutes. Participants must understand English. It excludes those with uncontrolled heart, lung or metabolic diseases, other neurological disorders affecting walking, recent leg injuries, or visual/communication disorders.Check my eligibility
What is being tested?
The study tests two types of treadmill training in people with Parkinson's: one that combines speed and step rhythm (cadence) and another that controls speed alone to see which method offers more benefits.See study design
What are the potential side effects?
Potential side effects may include fatigue due to exercise, muscle soreness, joint pain from repetitive movement on the treadmill, and an increased risk of falls during training sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 1 days
Treatment ~ Varies
Follow Up ~baseline and post-intervention (about 1 hour following the baseline)
This trial's timeline: 1 days for screening, Varies for treatment, and baseline and post-intervention (about 1 hour following the baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in the Gait Speed Determined based on the Time Measured by A Stop Watch and the 10-meter Walking Distance at Post-intervention Assessment Which Is about One Hour Later Than the Baseline Test.
Secondary outcome measures
Change from Baseline in Dynamic Gait Stability Assessed by the Feasible Stability Region Theory at Post-intervention Assessment Which Is about One Hour Later Than the Baseline Test.
Change from Baseline in Ground Reaction Force Assessed by Force Plates at Post-intervention Assessment Which Is about One Hour Later Than the Baseline Test.
Change from Baseline in the Step Cadence as Assessed by the Vicon Motion Capture System at Post-intervention Assessment Which Is about One Hour Later Than the Baseline Test.
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Traditional Training GroupExperimental Treatment1 Intervention
This arm will receive a single session treadmill training session in which only treadmill speed is controlled.
Group II: Advanced Training GroupExperimental Treatment1 Intervention
This arm will receive a single session treadmill training session in which both cadence and treadmill speed are controlled.

Find a Location

Who is running the clinical trial?

Georgia State UniversityLead Sponsor
57 Previous Clinical Trials
25,409 Total Patients Enrolled
Feng Yang, PhDPrincipal InvestigatorGeorgia State University
3 Previous Clinical Trials
148 Total Patients Enrolled

Media Library

Advanced treadmill walking Clinical Trial Eligibility Overview. Trial Name: NCT05239026 — N/A
Parkinson's Disease Research Study Groups: Advanced Training Group, Traditional Training Group
Parkinson's Disease Clinical Trial 2023: Advanced treadmill walking Highlights & Side Effects. Trial Name: NCT05239026 — N/A
Advanced treadmill walking 2023 Treatment Timeline for Medical Study. Trial Name: NCT05239026 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there capacity for more volunteers to join this clinical experiment?

"Affirmative. Clinicaltrials.gov indicates that recruitment for this study is currently taking place, with the initial posting occuring on March 21st 2022 and last update made April 16th of that same year. 20 participants are being sourced from a single trial site."

Answered by AI

What is the total participant quota for this experiment?

"Affirmative. According to the data hosted on clinicaltrials.gov, this medical study is actively looking for candidates; it was first posted on March 21st 2022 and has been recently updated on April 16th of that same year. The trial requires 20 participants at one site in particular."

Answered by AI

Does this research trial accept participants of at least 25 years of age?

"The specified age range for this trial is 18 to 89, with those under the age of majority being eligible."

Answered by AI

Who meets the criteria to partake in this experiment?

"This medical research requires the enrolment of 20 participants diagnosed with Parkinson's disease. The age range is 18 to 89, and all must be able to read English fluently. Additionally, each should fall within stages 1-3 according Hoehn and Yahr scale for PD motor impairment evaluation, as well as being independent walkers capable of ambulating 15m or more overground and enduring a treadmill session lasting at least quarter of an hour."

Answered by AI
~6 spots leftby Apr 2025